Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. Revenue 2010–2025
Altimmune, Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Altimmune, Inc. revenue for the quarter ending September 30, 2025 was 5000, a 0.00% increase year-over-year.
- Altimmune, Inc. revenue for the twelve months ending September 30, 2025 was 20000, a 94.71% decrease year-over-year.
- Altimmune, Inc. annual revenue for 2025 was 41000, a 105.00% increase from 2024.
- Altimmune, Inc. annual revenue for 2024 was 20000, a 95.31% decrease from 2023.
- Altimmune, Inc. annual revenue for 2023 was 426000, a 726.47% decrease from 2022.
- Altimmune, Inc. annual revenue for 2022 was -68000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Altimmune, Inc. Market Cap — FAQ
Altimmune, Inc. (ALT) market cap over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's market cap history?
The chart and table above show Altimmune, Inc.'s market cap by year and by quarter, including the growth rate.